Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:15 AM
Ignite Modification Date:
2025-12-25 @ 4:15 AM
NCT ID:
NCT04787120
Eligibility Criteria:
Inclusion Criteria:
* Patient presenting with an arterial abdominopelvic bleeding or imminent risk of bleeding, including visceral, muscular or GI territories, requiring embolization, along with angiographic abnormalities
* Patient for whom the use of SQUIDperi had been decided for an embolization
* Patient or authorized representative dully informed and having no objection to the clinical data collection and medical file access
* Patient \> 18 years
Exclusion Criteria:
* Patient with severe live failure
* Patient participating in another interventional study
* Vulnerable patients including pregnant women
* Patient not eligible for treatment with liquid embolic agent
* Patients presenting contra-indications to SQUIDperi as describes in the Informations For Use (IFU)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04787120
Study Brief:
Protocol Section:
NCT04787120